Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.

McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, LaFerla FM, Jenkins BG, Kowall NW, Dedeoglu A.

Brain Res. 2008 May 1;1207:225-36. doi: 10.1016/j.brainres.2008.01.095. Epub 2008 Feb 16.

2.

Application of MRS to mouse models of neurodegenerative illness.

Choi JK, Dedeoglu A, Jenkins BG.

NMR Biomed. 2007 May;20(3):216-37. Review.

PMID:
17451183
3.

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies.

McGeer PL, McGeer EG.

Neurobiol Aging. 2007 May;28(5):639-47. Epub 2006 May 11. Review.

PMID:
16697488
4.

A decade of modeling Alzheimer's disease in transgenic mice.

McGowan E, Eriksen J, Hutton M.

Trends Genet. 2006 May;22(5):281-9. Epub 2006 Mar 29. Review.

PMID:
16567017
5.

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy.

Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR Jr, Ugurbil K, Garwood M.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11906-10. Epub 2005 Aug 9.

6.

Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.

von Kienlin M, Künnecke B, Metzger F, Steiner G, Richards JG, Ozmen L, Jacobsen H, Loetscher H.

Neurobiol Dis. 2005 Feb;18(1):32-9.

PMID:
15649694
7.

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.

Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG.

Brain Res. 2004 Jun 25;1012(1-2):60-5.

PMID:
15158161
8.

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN.

J Neurosci. 2002 Mar 15;22(6):2246-54.

9.

Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH.

N Engl J Med. 2001 Nov 22;345(21):1515-21.

10.

Metabolic changes in quinolinic acid-lesioned rat striatum detected non-invasively by in vivo (1)H NMR spectroscopy.

Tkác I, Keene CD, Pfeuffer J, Low WC, Gruetter R.

J Neurosci Res. 2001 Dec 1;66(5):891-8.

PMID:
11746416
11.

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH.

Nature. 2001 Nov 8;414(6860):212-6.

PMID:
11700559
12.

Magnetic resonance spectroscopy in AD.

Valenzuela MJ, Sachdev P.

Neurology. 2001 Mar 13;56(5):592-8. Review.

PMID:
11261442
13.

Aggresomes, inclusion bodies and protein aggregation.

Kopito RR.

Trends Cell Biol. 2000 Dec;10(12):524-30. Review.

PMID:
11121744
15.

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.

Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC.

Neurology. 2000 Jul 25;55(2):210-7.

16.

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF.

J Neurochem. 2000 May;74(5):2108-19.

17.

MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.

Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ.

Neuroreport. 2000 Jan 17;11(1):211-3.

PMID:
10683860
18.

Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G.

Science. 1996 Oct 4;274(5284):99-102.

PMID:
8810256
19.

Probable Alzheimer disease: diagnosis with proton MR spectroscopy.

Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD.

Radiology. 1995 Apr;195(1):65-72.

PMID:
7892497
20.

Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.

Brand A, Richter-Landsberg C, Leibfritz D.

Dev Neurosci. 1993;15(3-5):289-98.

PMID:
7805581

Supplemental Content

Support Center